|
China Cyts Tours Holding Co., Ltd. (600138.SS) Avaliação DCF
CN | Consumer Cyclical | Travel Lodging | SHH
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
China Cyts Tours Holding Co., Ltd. (600138.SS) Bundle
Descubra o verdadeiro valor da China Cyts Tours Holding Co., Ltd. (600138Ss) com nossa calculadora DCF avançada! Ajuste as suposições essenciais, explore vários cenários e avalie como diferentes fatores influenciam a avaliação da China Cyts Tours Holding Co., Ltd. (600138Ss) - tudo dentro de um único modelo do Excel.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14,053.6 | 7,150.7 | 8,635.4 | 6,416.8 | 9,634.8 | 9,541.0 | 9,448.0 | 9,355.9 | 9,264.8 | 9,174.5 |
| Revenue Growth, % | 0 | -49.12 | 20.76 | -25.69 | 50.15 | -0.97436 | -0.97436 | -0.97436 | -0.97436 | -0.97436 |
| EBITDA | 1,196.4 | 345.0 | 532.4 | 199.9 | 1,103.1 | 650.1 | 643.7 | 637.5 | 631.3 | 625.1 |
| EBITDA, % | 8.51 | 4.83 | 6.16 | 3.12 | 11.45 | 6.81 | 6.81 | 6.81 | 6.81 | 6.81 |
| Depreciation | 296.1 | 275.3 | 281.9 | 468.3 | 398.9 | 394.2 | 390.4 | 386.6 | 382.8 | 379.1 |
| Depreciation, % | 2.11 | 3.85 | 3.26 | 7.3 | 4.14 | 4.13 | 4.13 | 4.13 | 4.13 | 4.13 |
| EBIT | 900.3 | 69.8 | 250.4 | -268.3 | 704.2 | 255.9 | 253.4 | 250.9 | 248.5 | 246.0 |
| EBIT, % | 6.41 | 0.97559 | 2.9 | -4.18 | 7.31 | 2.68 | 2.68 | 2.68 | 2.68 | 2.68 |
| Total Cash | 1,003.1 | 1,756.0 | 1,391.1 | 1,196.6 | 1,224.2 | 1,510.5 | 1,495.8 | 1,481.2 | 1,466.8 | 1,452.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 2,458.2 | 2,256.3 | 2,166.7 | 2,215.6 | 2,433.0 | 2,555.4 | 2,530.5 | 2,505.8 | 2,481.4 | 2,457.2 |
| Account Receivables, % | 17.49 | 31.55 | 25.09 | 34.53 | 25.25 | 26.78 | 26.78 | 26.78 | 26.78 | 26.78 |
| Inventories | 2,367.3 | 2,877.8 | 2,150.8 | 2,123.7 | 1,968.9 | 2,586.1 | 2,560.9 | 2,536.0 | 2,511.2 | 2,486.8 |
| Inventories, % | 16.84 | 40.24 | 24.91 | 33.1 | 20.43 | 27.11 | 27.11 | 27.11 | 27.11 | 27.11 |
| Accounts Payable | 1,727.1 | 1,406.2 | 1,370.9 | 1,071.1 | 1,147.4 | 1,458.4 | 1,444.2 | 1,430.1 | 1,416.2 | 1,402.4 |
| Accounts Payable, % | 12.29 | 19.66 | 15.87 | 16.69 | 11.91 | 15.29 | 15.29 | 15.29 | 15.29 | 15.29 |
| Capital Expenditure | -1,065.5 | -797.8 | -692.0 | -612.6 | -283.6 | -748.8 | -741.5 | -734.3 | -727.1 | -720.1 |
| Capital Expenditure, % | -7.58 | -11.16 | -8.01 | -9.55 | -2.94 | -7.85 | -7.85 | -7.85 | -7.85 | -7.85 |
| Tax Rate, % | 56.09 | 56.09 | 56.09 | 56.09 | 56.09 | 56.09 | 56.09 | 56.09 | 56.09 | 56.09 |
| EBITAT | 664.3 | 100.0 | 114.1 | -233.9 | 309.2 | 179.3 | 177.6 | 175.8 | 174.1 | 172.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -3,203.5 | -1,052.0 | 485.3 | -699.9 | 438.3 | -603.9 | -137.7 | -136.3 | -135.0 | -133.7 |
| WACC, % | 5.9 | 6.45 | 5.31 | 6.18 | 5.28 | 5.82 | 5.82 | 5.82 | 5.82 | 5.82 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1,017.0 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -136 | |||||||||
| Terminal Value | -3,566 | |||||||||
| Present Terminal Value | -2,687 | |||||||||
| Enterprise Value | -3,704 | |||||||||
| Net Debt | 3,998 | |||||||||
| Equity Value | -7,701 | |||||||||
| Diluted Shares Outstanding, MM | 719 | |||||||||
| Equity Value Per Share | -10.72 |
What You Will Receive
- Customizable Excel Template: A tailored Excel-based DCF Calculator featuring pre-populated financial data for China Cyts Tours Holding Co., Ltd. (600138SS).
- Authentic Data: Access to historical figures and forward-looking projections (highlighted in the yellow cells).
- Flexible Forecasting: Adjust key assumptions such as revenue growth, EBITDA %, and WACC as needed.
- Real-Time Calculations: Immediately observe how your inputs affect the valuation of China Cyts Tours Holding Co., Ltd. (600138SS).
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts alike.
- Intuitive Design: Organized for clarity and ease of navigation, complete with step-by-step guidance.
Key Features
- Pre-Loaded Data: Historical financial reports and pre-filled forecasts for China Cyts Tours Holding Co., Ltd. (600138SS).
- Fully Customizable Inputs: Adjust WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
- Real-Time Results: Watch the intrinsic value of China Cyts Tours Holding Co., Ltd. (600138SS) update instantly.
- Comprehensive Visual Outputs: User-friendly dashboard charts showcase valuation results and essential metrics.
- Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.
How It Operates
- 1. Access the Template: Download and open the Excel spreadsheet containing China Cyts Tours Holding Co., Ltd.’s (600138SS) preloaded data.
- 2. Adjust Inputs: Modify critical parameters such as growth rates, WACC, and capital expenditures.
- 3. Instant Results: The DCF model instantly computes intrinsic value and NPV based on your inputs.
- 4. Explore Scenarios: Evaluate various forecasts to understand different valuation scenarios.
- 5. Present With Assurance: Share professional valuation analyses to back up your strategic decisions.
Why Opt for This Calculator?
- Reliable Data: Authentic financial information for China Cyts Tours Holding Co., Ltd. (600138SS) ensures accurate valuation outputs.
- Personalizable: Tailor essential variables like growth rates, WACC, and tax rates to align with your forecasts.
- Efficient: Pre-built calculations save you the time of starting from the ground up.
- Professional Quality: Crafted for investors, financial analysts, and consultants.
- User-Friendly: An intuitive design and clear step-by-step guidance make it accessible for all users.
Who Can Benefit from This Product?
- Investors: Accurately assess the fair value of China Cyts Tours Holding Co., Ltd. (600138SS) before making investment choices.
- CFOs: Utilize a professional-grade DCF model for comprehensive financial reporting and analysis.
- Consultants: Easily customize the template for client valuation reports.
- Entrepreneurs: Acquire insights into the financial modeling practices employed by leading corporations.
- Educators: Implement it as a resource for teaching valuation techniques and methodologies.
Overview of the Template Features
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations.
- Real-World Data: China Cyts Tours Holding Co., Ltd. (600138SS)’s historical and projected financials preloaded for in-depth analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Charts and tables that provide clear, actionable results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.